Treating Achilles Tendon Rupture in Rats with Bone-Marrow-Cell Transplantation Therapy

Okamoto, Naofumi; Kushida, Taketoshi; Oe, Kenichi; Umeda, Masayuki; Ikehara, Susumu; Iida, Hirokazu
December 2010
Journal of Bone & Joint Surgery, American Volume;12/1/2010, Vol. 92-A Issue 17, p2776
Academic Journal
Background: Bone marrow cells possess multipotentiality and have been used for several treatments. We hypothesized that bone marrow cells might differentiate into regenerated tendon and that several cytokines within bone marrow cells might accelerate tendon healing. Therefore, we treated Achilles tendon ruptures in a rat model with transplantation of whole bone marrow cells. Methods: Nine F344/NsIc (Fisher) rats were the source of bone marrow cells and mesenchymal stem cells as well as normal Achilles tendons. Eighty-seven Fisher rats were used for the experiments. The rats were divided into three groups: the BMC group (bone marrow cells injected around the tendon), the MSC group (mesenchymal stem cells injected around the tendon), and the non-treated control group (incision only). Outcome measures included mechanical testing, collagen immunohistochemistry, histological analysis, and reverse transcription-polymerase chain reaction to detect expression of transforming growth factor-β (TGF-β) and vascular endothelial growth factor (VEGF). Results: The ultimate failure load in the BMC group was significantly greater than that in the non-treated or the MSC group at seven days after incision (3.8 N vs. 0.9 N or 2.1 N, p <0.016) and at fourteen days after incision (10.2 N vs. 6.1 N or 8.2 N, p < 0.016). The ultimate failure load in the BMC group at twenty-eight days after incision (33.8 N) was the same as that of normal tendon (34.8 N). The BMC group demonstrated stronger staining for type-III collagen at seven days after incision and stronger staining for type-I collagen at twenty-eight days than did the MSC group. Expression of TGF-β and VEGF in the BMC group was significantly increased compared with that in the other groups at four days after incision (TGF-β: 1.6 vs. 1.3 or 0.6, p < 0.01; VEGF: 1.7 vs. 1.1 or 0.9, p < 0.01). Conclusions: Transplantation of whole bone marrow cells may be a better and more readily available treatment for Achilles tendon rupture than cultured mesenchymal stem cells. Clinical Relevance: The present study provides evidence that transplantation of bone marrow cells may be a promising therapy for the treatment of Achilles tendon rupture.


Related Articles

  • Cell Therapy of Refractory Crohn’s Disease. Knyazev, O. V.; Parfenov, A. I.; Shcherbakov, P. L.; Ruchkina, I. N.; Konoplyannikov, A. G. // Bulletin of Experimental Biology & Medicine;Nov2013, Vol. 156 Issue 1, p139 

    We analyzed medium-term efficiency and safety of biological therapy of Crohn’s disease, in particular transplantation of allogenic mesenchymal stromal bone marrow cells and anticytokine therapy with selective immunosuppressive agents. It was found that both methods of biological therapy...

  • The Role of Systemically Delivered Bone Marrow-Derived Mesenchymal Stem Cells in the Regeneration of Periodontal Tissues. Meijiao Yu; Shaohua Ge; Fang Wang; Yong Wen; Xinlong Yan; Quan Zeng; Wen Yue; Pishan Yang; Xuetao Pei // Oral & Craniofacial Tissue Engineering;2011, Vol. 1 Issue 4, p331 

    Purpose: Recent studies have shown that periodontal ligament stem cells (PDLSCs) play a key role in periodontal regeneration. However, the origin of these cells remains unclear. Meanwhile, bone marrow is thought to be the most common source of adult stem cells in many tissues and organs. Thus,...

  • Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia. McGinley, Lisa; McMahon, Jill; Strappe, Padraig; Barry, Frank; Murphy, Mary; O'Toole, Daniel; O'Brien, Timothy // Stem Cell Research & Therapy;2011, Vol. 2 Issue 2, p1 

    Introduction: A combination of gene and cell therapies has the potential to significantly enhance the therapeutic value of mesenchymal stem cells (MSCs). The development of efficient gene delivery methods is essential if MSCs are to be of benefit using such an approach. Achieving high levels of...

  • Intravenous administration of mesenchymal stem cells improve functional recovery after traumatic brain injury in rats. Anbari, F.; Khalili, M. A.; Bahrami, A. R.; Aflatounian, B.; Khoradmehr, A. // Iranian Journal of Reproductive Medicine;AprSupp, p63 

    Introduction: Traumatic brain injury (TBI) is a major cause of mortality worldwide. The clinical studies have proven cell therapy as a major option to improve the brain function post trauma, and by possible regeneration of the nervous system. The aim was to investigate the role of intravenous...

  • Umbilical Cord Perivascular Cells: A Mesenchymal Cell Source for Treatment of Tendon Injuries. Emrani, Hamideh; Davies, John E. // Open Tissue Engineering & Regenerative Medicine Journal;2011, Vol. 4, p112 

    Objective: To model the healing that umbilical cord perivascular cells effect in equines, we have used human umbilical cord perivascular cells (HUCPVCs) to repair tendon damage in a collagenase tendon injury model in immunecompromised rats. Animals: 48 Nude rats (Crl:NIH-Foxn1rnu) of 200-250 g...

  • Chondroitin sulfates in the developing rat hindbrain confine commissural projections of vestibular nuclear neurons.  // Neural Development;2012, Vol. 7 Issue 1, p6 

    The article focuses on the study which discusses the role of chondroitin sulfate (CS) proteoglycans in embryonic neural environments according to which, matrix proteoglycans regulate axonal projections. It states that the experiments were done on the newly born neurons of the rat and the...

  • The SDF-1/CXCR4 axis regulates migration of transplanted bone marrow mesenchymal stem cells towards the pancreas in rats with acute pancreatitis. JIAN GONG; ONG-BO MENG; JIE HUA; ZHEN-SHUN SONG; ZHI-GANG HE; BO ZHOU; MING-PING QIAN // Molecular Medicine Reports;2014, Vol. 9 Issue 5, p1575 

    Stromal cell-derived factor-1 (SDF-1) and its receptor, CXC chemokine receptor-4 (CXCR4), are important regulators in the migration of bone marrow mesenchymal stem cells (BMSCs). However, the mechanisms underlying this effect in acute pancreatitis (AP) have not been investigated. In this study,...

  • Efficacy of Topical Mesenchymal Stem Cell Therapy in the Treatment of Experimental Dry Eye Syndrome Model. Beyazyıldız, Emrullah; Alpaslan Pınarlı, Ferda; Beyazyıldız, Özlem; Rümeysa Hekimoğlu, Emine; Acar, Uğur; Necati Demir, Muhammed; Albayrak, Aynur; Kaymaz, Figen; Sobacı, Güngör; Delibaşı, Tuncay // Stem Cells International;2014, p1 

    Purpose. The current study was set out to address the therapeutic efficacy of topically applied mesenchymal stem cells (MSCs) on dry eye syndrome (DES) induced by benzalkonium chloride (BAC) in rats. Methods. Rats were divided into two groups just after establishment of DES. Eye drops containing...

  • Primed Mesenchymal Stem Cells Alter and Improve Rat Medial Collateral Ligament Healing. Saether, Erin; Chamberlain, Connie; Aktas, Erdem; Leiferman, Ellen; Brickson, Stacey; Vanderby, Ray // Stem Cell Reviews & Reports;Feb2016, Vol. 12 Issue 1, p42 

    Cell therapy with mesenchymal stem cells (MSCs) can improve tissue healing. It is possible, however, that priming MSCs prior to implantation can further enhance their therapeutic benefit. This study was then performed to test whether priming MSCs to be more anti-inflammatory would enhance...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics